Propentofylline improves learning and memory deficits in rats induced by β-amyloid protein-(1-40)

European Journal of Pharmacology

Volumn 349, Issue 1, 1998, Pages 15-22

  Yamada, Kiyofumi ^a   Tanaka, Tomoko ^a,b   Senzaki, Kouji ^a   Kameyama, Tsutomu ^b   Nabeshima, Toshitaka ^a  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b MEIJO UNIVERSITY   (Japan)

Author keywords

Amyloid protein; (Rat); Alzheimer's disease; Choline acetyltransferase; Learning; Memory; Propentofylline

Indexed keywords

AMYLOID BETA PROTEIN; PROPENTOFYLLINE;

ALZHEIMER DISEASE; AMNESIA; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; LEARNING; MALE; MEMORY; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT;

ADMINISTRATION, ORAL; AMYLOID BETA-PROTEIN; ANIMALS; AVOIDANCE LEARNING; CHOLINE O-ACETYLTRANSFERASE; HABITUATION, PSYCHOPHYSIOLOGIC; INJECTIONS, INTRAVENTRICULAR; LEARNING; MALE; MAZE LEARNING; MEMORY; NOOTROPIC AGENTS; PEPTIDE FRAGMENTS; RATS; RATS, WISTAR; XANTHINES;

EID: 0032524558     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(98)00166-6     Document Type: Article

References (32)

1. Banati R.B., Gehrmann J., Schubert P., Kreutzberg G.W. Cytotoxicity of microglia. Glia. 7:1993;111-115.
2. Bartus R.T., Dean R.L., Beer B., Lippa A.S. The cholinergic hypothesis of geriatric memory dysfunction. Science. 217:1982;408-417.
3. Fredholm B.B., Lingström K. The xanthine derivative 1-(5′-oxohexyl)-3-methyl-7-propyl xanthine (HWA 285) enhances the actions of adenosine. Acta Pharmacol. Toxicol. 58:1986;187-192.
4. Friden P.M., Walus L.R., Watson P., Doctrow S.R., Kozarich J.W., Backman C., Bergman H., Hoffer B., Bloom F., Granholm A.C. Blood-brain barrier penetration and in vivo activity of an NGF conjugate. Science. 259:1993;373-377.
5. Fuji K., Hiramatsu M., Hayashi S., Kameyama T., Nabeshima T. Effects of propentofylline, a NGF synthesis stimulator, on alterations in muscarinic cholinergic receptors induced by basal forebrain lesion in rats. Neurosci. Lett. 150:1993;99-102.
6. Fuji K., Hiramatsu M., Kameyama T., Nabeshima T. Effects of repeated administration of propentofylline on memory impairment produced by basal forebrain lesion in rats. Eur. J. Pharmacol. 236:1993;411-417.
7. Hadlicka O., Kowarek J., Wright A.J.A. The effect of a xanthine derivative, 1-(5′-oxohexyl)-3-methyl-7-propylxanthine (HWA 285), on heart performance and regional blood flow in dogs and rabbits. Br. J. Pharmacol. 72:1981;723-730.
8. Hefti F., Dravid A., Hartikka J. Chronic intraventricular injections of nerve growth factor elevate hippocampal choline acetyltransferase activity in adult rats with partial septo-hippocampal lesions. Brain Res. 293:1984;305-311.
9. Honegger P., Lenoir D. Nerve growth factor (NGF) stimulation of cholinergic telencephalic neurons in aggregating cell culture. Dev. Brain Res. 3:1982;229-238.
10. Itoh A., Nitta A., Nadai M., Nishimura K., Hirose M., Hasegawa T., Nabeshima T. Dysfunction of cholinergic and dopaminergic neuronal systems in β-amyloid protein-infused rats. J. Neurochem. 66:1996;1113-1117.
11. Kaneda N., Nagatsu T. Highly sensitive assay for choline acetyltransferase activity by high-performance liquid chromatography with electrochemical detection. J. Chromatogr. 341:1985;23-30.
12. Marcusson J., Rother M., Kittner B., Rossner M., Smith R.J., Babic T., Folnegovic-Smalc V., Moller H.J., Labs K.H. A 12-month, randamized, placebo-controlled trial of propentofylline (HWA285) in patients with dementia according to DMS III-R. Dementia Geriatr. Cogn. Disord. 8:1997;320-328.
13. Morris R.G.M. Developments of water-maze procedure for studying spatial learning in the rat. J. Neurosci. Methods. 11:1984;47-60.
14. Mrsulja B.B., Micic D.V., Djuricic B.M. Gerbil stroke model: an approach to the study of therapeutic aspects of postischemic brain edema. Adv. Biosci. 43:1983;45-62.
15. Nabeshima, T., Itoh, A., 1996. Toxicity of β-amyloid protein: neurochemical, histological and behavioral changes. In: Iqbal, K. et al. (Eds.), Alzheimer's Disease: Biology, Diagnosis and Therapeutics. Chichester Press, Chichester, pp. 623-630.
16. Nabeshima T., Itoh A. Alzheimer's disease animal models induced by continuous infusion of β-amyloid protein and anti-nerve growth factor antibody. Rev. Heteroatom Chem. 16:1997;229-255.
17. Nabeshima T., Nitta A. Memory impairment and neuronal dysfunction induced by β-amyloid protein in rats. Tohoku J. Exp. Med. 174:1994;241-249.
18. Nabeshima T., Ogawa S., Ishimaru H., Kameyama T., Fukuta T., Takeuchi R., Hayashi K. Memory impairment and morphological changes in rats induced by active fragment of anti-nerve growth factor-antibody. Biochem. Biophys. Res. Commun. 175:1991;215-219.
19. Nabeshima T., Nitta A., Hasegawa T. Impairment of learning and memory and the accessory symptom in aged rats as senile dementia model (3): oral administration of propentofylline produces recovery of reduced NGF content in the brain of aged rats. Jpn. J. Psychopharmacol. 13:1993;89-95.
20. Nitta A., Itoh A., Hasegawa T., Nabeshima T. β-Amyloid protein-induced Alzheimer's disease animal model. Neurosci. Lett. 170:1994;63-66.
21. Nitta A., Ogihara Y., Onishi J., Hasegawa T., Furukawa S., Nabeshima T. Propentofylline prevents neuronal dysfunction induced by infusion of anti-nerve growth factor antibody into the rat septum. Eur. J. Pharmacol. 307:1996;1-6.
22. Nitta A., Fukuta T., Hasegawa T., Nabeshima T. Continuous infusion of β-amyloid protein into cerebral ventricle induces learning impairment and neuronal and morphological degeneration. Jpn. J. Pharmacol. 73:1997;51-57.
23. 11C-nicotine binding, blood flow, EEG, and verbal episodic memory in an Alzheimer patient (case report) J. Neural Transm. Parkinson's Dis. Dementia Sect. 4:1992;79-95.
24. Paxinos, G., Watson, C., 1986. The Rat Brain in the Stereotaxic Coordinates, Academic Press, New York.
25. Platel A., Porsolf R.D. Habituation of exploratory activity in mice: a screening test for memory enhancing drugs. Psychopharmacology. 78:1982;346-352.
26. Shinoda I., Furukawa Y., Furukawa S. Stimulation of nerve growth factor synthesis/secretion by propentofylline in cultured mouse astroglial cells. Biochem. Pharmacol. 49:1990;1813-1816.
27. Sims N.R., Bowen D.M., Allen S.J., Smith C.C.T., Neary D., Thomas D.J., Davison A.N. Presynaptic cholinergic dysfunction in patients with dementia. J. Neurochem. 40:1983;503-509.
28. Stefanovich V., Nagata K. Effects of propentofylline and cinepazide on cerebral energy metabolism in nitrogen breathing rats. IRCS Med. Sci. 11:1983;972.
29. Wu P.H., Barraco R.A., Phillis J.W. Further studies on the inhibition of adenosine uptake into rat brain synaptosomes by adenosine derivatives and methyl xanthines. Gen. Pharmacol. 15:1984;251-254.
30. Yamada K., Nitta A., Saito T., Hu J., Nabeshima T. Changes in ciliary neurotrophic factor content in the rat brain after continuous intracerebroventricular infusion of β-amyloid (1-40) protein. Neurosci. Lett. 201:1995;155-158.
31. Yamada K., Noda Y., Hasegawa T., Komori Y., Nikai T., Sugihara H., Nabeshima T. The role of nitric oxide in dizocilpine-induced impairment of spontaneous alternation behavior in mice. J. Pharmacol. Exp. Ther. 276:1996;460-466.
32. Yamada K., Nitta A., Hasegawa T., Fuji K., Hiramatsu M., Kameyama T., Furukawa Y., Hayashi K., Nabeshima T. Orally active NGF synthesis stimulators: potential therapeutic agents in Alzheimer's disease. Behav. Brain Res. 83:1997;117-122.